SlideShare a Scribd company logo
By
DR Mohammed
Riyas
INTRODUCTION
 An acoustic neuroma (also called
vestibular schwannoma) is a
benign tumor arising from
abnormally proliferative shwann
cells , which envelope the lateral
portion of the vestibular nerve in
Little things about
CP angle
CP angle tumors
 Represents 10 % of all intracranial
tumors.
 Fatal without treatment.
 VS account for 78 % of CPA tumors
- mostly from vestibular branch of
VIIIth Nerve.
 Variety of other tumors arise from
this area like meningioma , CN
swannomas , dermoid tumors ,
arachnoid cysts ,lipomas ,
Anatomy of CP angle
 CPA – Irregularly shaped potential
space in the posterior fossa of the
brain .
 Anteriorly – posterior surface of
temporal bone .
 Posteriorly – anterior surface of the
cerebellum.
 Medially – cisterns of the pons &
medulla and olive.
 Superiorly – inferior border of pons
Anatomy of CP angle
 CN s V ( superiorly ) , IX,X,XI
(inferiorly ) transverse the cephalic
and caudal extent of the CPA.
 The central structures crossing the
CPA to & from the IAC are CN VII &
VIII s carrying with them a fine
sheet of arachnoid tissue upto IAC.
 Schwann cells sorround these
nerves beginning in the IAC , near
the porus at the Obersteiner-
Redlich zone.
Anatomy of CP angle
 CN s V ( superiorly ) , IX,X,XI
(inferiorly ) transverse the cephalic
and caudal extent of the CPA.
 The central structures crossing the
CPA to & from the IAC are CN VII &
VIII s carrying with them a fine
sheet of arachnoid tissue upto IAC.
 Schwann cells sorround these
nerves beginning in the IAC , near
the porus at the Obersteiner-
Redlich zone.
Anatomy of CP angle
AICA is the main artery in the
CPA and is the source of the
labrynthine artery .
The labrynthine artery
courses via the IAC & is an
end artery for the hearing and
balance organs.
Vestibular schwannoma
Nerve sheath tumors of the
superior and inferior
vestibular nerves.
They arise in the medial part
of the IAC or the lateral part
of the CPA and cause clinical
symptoms by displacing ,
distorting or compressing
Vestibular schwannoma
 Mean incidence range – 9.1 tmr/yr to
13 tmr/yr( as per SB)
 0.7 to 1.2 VS per lakh population/yr (
ballenger )
 Types - Sporadic ( 95%) and non
sporadic ( 5%)
 Age of presentation – 40 to 60 yrs.
 Age of presentation is less in non
sporadic ( 20-30 yrs )
Tumor biology
 Equal frequency in sup and inf
vestibular ( but recent japanese
studies suggested 85 % from inf
vestibular )
 Arise from schwann cells within
the IAC – lateral to O-R zone in the
area of scarpa ganglion.
 Schwannomas rarely arise from
the cochlear nerve & are rarely
Tumor pathogenesis
 Owing to mutations in the gene for
the tumor suppresor protein MERLIN
located on chr 22q12.
 Formation of VS requires mutation of
both copies of the merlin gene.
 Somatic mutations in both copies of
merlin gene results in sporadic VSs .
 Familial VS occuring in NF 2 requires
only one somatic mutation event .(
inherit one )
Tumor pathogenesis
 NF2 is autosomal recessive at gene
level but inheritance is autosomal
dominant ( pseudodominant )
 A mutation in the normal allele leads
to bilateral VS by the age of 20.
 Genetic screens for the NF2 mutation
have been developed and are the basis
for genetic counselling for family
members of NF2 patients
Tumor pathogenesis
 Biochemical factors- VS express
neuregulin ,which controls survival
and proliferation of schwann cells and
its receptors erbB2 & erbB3.
 FGF ,TGF B1 , PDGF & VEGF all these
contribute to VS proliferation.
 VS may accelerate during pregnancy.
pathology
 GROSS :
◦ VS have a smooth surface with a yellow to
gray color.
◦ Tumor is usually solid ,with occasional
cystic components and therefore has a
firm to soft texture depending on solid to
cystic components.
 MICROSCOPIC :
◦ Capsule – 3 to 5 micrometer in thickness.
◦ Two morphological tissue types – Antony
A & Antony B areas
T UMOR DEVELOPMENT
Develops in nerve sheath
Compresses rather than invading the
nerve
Gradually fills all the IAC
Protrudes out of the porus
T UMOR DEVELOPMENT-
extrameatally
Extrameatal expansion into the large &
empty pontine cistern
Displacement and stretching of the VII &
VIII th CN on the anterior
Compress cerebellum and trigeminal N
aspect of the tumor & of the AICA
on the inferior aspect
(During this time IAM continues to become
more & more widened )
which leads gradually to
hydrocephalus
T UMOR DEVELOPMENT-
extrameatally
Tumor may extent to the tentorium & can
obstruct the
cochlear aqueduct
The AICA & lower cranial nerves are also
displaced & become closely
Overtime , the trigeminal & abducens
Adherent to the inf surface of
tumor.
over the surface of the tumor and
get thinned.
1. 2.
3.
4.
INTRACANALICULAR CISTERNAL
COMPRESSIVE HYDROCEPHALIC
Tumor development…..
 Periods of growth are intermixed
b/w slow growth & peroid of
quescence.
 Occasionally tumor may undergo
rapid expansion owing to cystic
degeneration or hemmorhage into
the tumor.
 The initial intracanalicular growth
effects the vestibulocochlear nerve
Stage 1
Stage 2
Stage 3
Cerebellopontine Angle:
Large Acoustic Neuroma: Tumors over 2.5 centimeters (this one is 2.6 cm) become impacted
into the brainstem and cerebellum. Complications associated with surgery and radiation are
higher. It is difficult to deliver an adequate dose of radiation to control tumor growth without
excessive dosing to the brainstem in tumors larger than this.
Symptoms & signs
 Intracanalicular:
◦ Hearing loss (UL progressive ), tinnitus, vertigo
◦ Loss of speech discrimination out of propotion to HL
 Cisternal:
◦ Worsened hearing and dysequilibrium
 Compressive:
◦ Occasional occipital headache
◦ CN V: Midface, corneal hypesthesia
◦ CN VII : Hitzelberger’s sign, loss of taste and reduced
lacrimation on Schirmer’s test ,facial weakness ( late)
◦ CN II , IV , VI : visual acquity and diplopia
Symptoms & signs
 Hydrocephalic:
◦ Fourth ventricle compressed and obstructed
◦ Headache, visual changes, altered mental status
◦ Nausea and vomiting
◦ On examination : ICP and pappiledema.
 Compression of CN IX & X
◦ Dysphagia , aspiration and hoarseness
◦ Poor gag reflex and VC paralysis.
 Cerebellar involvement( late )
◦ Incoordination , widely based gate , tendency to fall
owards affected side
Symptoms & signs
 Brainstem involvement:
• There is ataxia, weakness and numbness of arms and legs
with exaggerated tendon reflexes.
Jackler Staging System
STAGE TUMOUR SIZE
Intra canalicular Tumour confined to IAC
I (Small) <10mm
II(Medium) 11-25mm
III(Large) 25-40mm
IV(Giant) >40mm
Tumor Growth Rate
Duration of Symptoms Prior to
Diagnosis
SYMPTOMS YEARS
Hearing loss 3.9
Vertigo 3.6
Tinnitus 3.4
Headache 2.2
Dysequilibrium 1.7
Trigeminal 0.9
Facial 0.6
Diagnostic evaluation
 Average patient will require 4 years from the
onset of symptoms to diagnosis.
 Majority will present with complaints of UHL, UT,
Vertigo , dysequilibrium, facial numbness ,
weakness or spasm.
 Initial step in evaluation includes an audiologic
assessment .if it suggests a retrocochlear lesion ,
then imaging of the CPA is performed .
 Vestibular testing lacks specificity in diagnosis of VS
AUDIOLOGICAL EVALUATION
 Includes PTA , Speech discrimination score
(SDS) , Acoustic reflex threshold & acoustic
reflex decay
 PTA of patients with VS shows assymetric ,
down sloping , high frequency SNHL in almost
70% of patients
AUDIOLOGICAL EVALUATION
 Retrocochlear HL causes SDS to be lower than
predicted by the pure tone thresholds.
 This out of propotion is furthur accenuated
when retested at a higher speech intensity
( roll over phenomenon )
 Loss of acoustic reflex or acoustic reflex decay is
noted in most patients with VS
audiological tests
Cochlear Retrocochlear
a) Pure tone audiometry Sensorineural hearing loss Sensorineural hearing loss
b) Speech discrimination
score
<90% Very poor
c) Roll over phenomenon Absent Present
d) Recruitment Present Absent
e) SISI Over 70% 0-20%
f) Threshold tone decay
test
<25db >25db
g) Stapedial reflex Present Absent
i) Stapedial reflex decay
test
Normal Absent
VESTIBULAR TESTING
 Not sensitive nor specific for diagnosing VS
 The MC test used is ENG with caloric testing.
 Shows reduced caloric response in the affected ear.
 The extent of vestibular function present predicts the
amount of post op vertigo.
 The location of VS on the inf or sup Vestibular N may
also be predicted.
AUDITORY BRAINSTEM RESPONSE
 In patients with VS , the ABR is partially or
completely absent , or there is a delay in
latency of wave V on the affected side.
 An interaural delay of wave V greater than
0.2 ms is considered abnormal. ( 40-60 % )
 Overall ABR has a sensitivity of > 90% &
specificity of > 90 % in detecting VS.
AUDITORY BRAINSTEM RESPONSE
 In 20-30 % there are no identifiable
waveforms even with insignificant HL in
higher frequencies.
 In 10-20 % only wave I is present.
BERA patterns in AN
Imaging studies
 VS is definitely identified MC via an imaging study.
 Earlier plain film radiograghs and polytomographs
 Introduction of CT in 1970 allowed axial imaging
with improved bone & soft tissue evaluation.
 With the addition of iv iodinated contrast agent
,90 % of VS are enhanced furthur improving
diagnostic accuracy.
Imaging studies
 Intracanalicular tumors & tumors extending less
than 5 mm into the CPA frequently are missed
with contrast enhanced CT.
 Accuracy improved by air-contrast cisternography.
 MRI was introduced in 1980 & has become the
GOLD standard for VS
Imaging studies
 MRI :
 VII & VIII nerves as well as cerebellum ,brainstem , vasculature
& other structures are well visualized on MRI
 The addition of gadolinium furthur enhanced the diagnostic
accuracy
 Typically a series of T1 weighed images in which CSF is dark
and fat is bright, T1 with gadolinium contrast , T2 In which
CSF is bright is used.
 A hypointense globular mass centered over the IAC on T1 With
enhancement on gadolinium.
 VS are iso-to hypointense on T2.
 T2 fast spin echo MRI without contrast as screening.
MRI Brain
Isointense to brain,
hyperintense to CSF
Hyperintense to brain,
hypointense to CSF
management options
 The primary management of VSs is surgical removal.
 Roles of observation and radiotherapy are currently for
the pts,who cannot tolerate a surgical procedure or have
a life span of < 5 yrs.
 Surgical approaches to the CPA include:
◦ Translabrynthine
◦ Retrosigmoid
◦ Middle fossa craniotomies.
management options
 The appropriate approach for a particular
pt. is based on the hearing status , size of
the tumor , extent of IAC involvement and
experience of the surgeon
 The approaches are either hearing
preservative or ablating.
 The retrosigmoid & middle fossa
approaches are hearing preserving, while
translabrynthine approach is otherwise.
management options
 The middle fossa approach is well suited for the
pts with good hearing and tumor<2cm.
 The retrosigmoid approach is well suited for
those with good hearing and tumor<4cm and
not involving the lateral part of IAC.
 The translabrynthine approach causes total
hearing loss and so is appropriate for the pts with
poor hearing(PTA>30dB) or pts with good
hearing and tumors not accessible by the hearing
preserving approach.
management options
 Three critical issues inherent to all the three techniques are:
◦ Extent of exposure of IAC and CPA
◦ Identification and preservation of the facial nerve
◦ extent of brain retraction
 These operations use electro physiologic
monitoring of CN VII and ABR in hearing
preserving approach.
Middle Fossa Approach.
Translabyrinthine Approach
Suboccipital Approach
Surgical Approaches
Factors that influence surgical approach selection
•Age
•Hearing status
•Tumour size
•Surgeon’s preference.
Translabrynthine approach
 The primary approach for removal of VS.
 Most direct route to the CPA & requires
minimal cerebellar retraction.
 Identification of facial n is possible.
 Surgeons can ensure complete removal bcz
fundus of IAC is widely exposed.
 Immediate repair of facial n possible.
 Recovery is quite rapid with minimal pain and
excellent facial n results
Translabrynthine approach
 Obvious disadvantage is sacrifice of any residual
hearing.
 Technique :
◦ A postauricular incision is made 2 cm behind sulcus
◦ Complete mastoidectomy is done,with identification of
the middle fossa dura, sigmoid sinis , LSSC , fossa incudis
& facial n
◦ The sigmoid sinus is decompressed with a diamond burr
Translabrynthine approach
◦ A labrynthectomy is begun by removal of bone in the
sinodural angle along the horizontal scc
◦ Each SCC is then opened and followed into the vestibule,
with care taken to identify the ampulla of each SCC and
the subarcuate artery
◦ A bone is removed along the posterior fossa dura medial
to sigmoid sinus , the endolymphatic duct and sac are
encountered.
Translabrynthine approach
◦ Jugular bulb location is defined by locating ampulla of
posterior canal. ( inferior extent of dissection )
◦ Bone is removed around the inferior aspect of IAC until
the cochlear aqueduct is identified
◦ Posterior aspect of the canal is skeletonized until the
superior edge of the internal canal is identified
◦ Bone is then carefully removed between th e middle
fossa dura & the IAC
Translabrynthine approach
◦ Once the medial portion of the IAC is exposed for 270
the remaining piece of porus may be carefully removed
◦ Laterally the transverse crest should be identified at the
fundus of the IAC.
◦ Superiorly , the Bills Bar is identified together with the
labrynthine portion of the facial n
◦ The posteroir fossa dura is opened inferior to and parallel
to the superior petrosal sinus over the midportion of the
IAC
0
Translabrynthine approach
◦ Using the bills bar as guide , and with a fine hook , the
surgeon seperates the superior vest n from facial nerve.
◦ The capsule of the tumor is incised , & the tumor is
gutted with house urban dissector
0
 Radiotherapy :-
1. Conventional radiotherapy by external beam
has no role in the treatment of Acoustic Neuromas
due to low tolerance of CNS to radiation.
2. X – or Gamma knife surgery.
THANK YOU
Acoustic neuroma
Acoustic neuroma

More Related Content

What's hot

Acoustic neuroma ENT REVISION TOPIC
Acoustic neuroma ENT REVISION TOPIC Acoustic neuroma ENT REVISION TOPIC
Acoustic neuroma ENT REVISION TOPIC
TONY SCARIA
 
Cholesteatoma
CholesteatomaCholesteatoma
Cholesteatoma CME
Cholesteatoma CMECholesteatoma CME
Carcinoma of hypopharynx
Carcinoma of hypopharynxCarcinoma of hypopharynx
Carcinoma of hypopharynx
Dr Krishna Koirala
 
Mucosal folds and ventilation of middle ear
Mucosal folds and ventilation of middle ear  Mucosal folds and ventilation of middle ear
Mucosal folds and ventilation of middle ear
AlkaKapil
 
Ossiculoplasty
OssiculoplastyOssiculoplasty
Ossiculoplasty
Md Roohia
 
Vestibular schwannoma
Vestibular schwannomaVestibular schwannoma
Vestibular schwannoma
praneeth koduru
 
Endoscopic anatomy of Retrotympanum; Middle ear
Endoscopic anatomy of Retrotympanum; Middle earEndoscopic anatomy of Retrotympanum; Middle ear
Endoscopic anatomy of Retrotympanum; Middle ear
Prasanna Datta
 
Canal wall up Mastoidectomy ( Intact Bridge Mastoidectomy) by Dr.Aditya Tiwari
Canal wall up Mastoidectomy ( Intact Bridge Mastoidectomy) by Dr.Aditya TiwariCanal wall up Mastoidectomy ( Intact Bridge Mastoidectomy) by Dr.Aditya Tiwari
Canal wall up Mastoidectomy ( Intact Bridge Mastoidectomy) by Dr.Aditya Tiwari
Aditya Tiwari
 
Middle ear implants
Middle ear implantsMiddle ear implants
Middle ear implants
Vinod M K
 
Phonosurgery
PhonosurgeryPhonosurgery
Phonosurgery
Yousuf Choudhury
 
Stroboscopy
StroboscopyStroboscopy
Stroboscopy
Sanjay Maharjan
 
Ossiculoplasty
OssiculoplastyOssiculoplasty
Ossiculoplasty
Ajay Manickam
 
Esthesioneuroblastoma (ENB)
Esthesioneuroblastoma (ENB)Esthesioneuroblastoma (ENB)
Esthesioneuroblastoma (ENB)
Dr. Prashant Surkar
 
OTOSCLEROSIS
OTOSCLEROSISOTOSCLEROSIS
OTOSCLEROSIS
Suraj Dhara
 
Glomus Tumour
Glomus TumourGlomus Tumour
Glomus Tumour
Utkal Mishra
 
Phonosurgery
PhonosurgeryPhonosurgery
Phonosurgery
Vaibhav Lahane
 

What's hot (20)

Acoustic neuroma ENT REVISION TOPIC
Acoustic neuroma ENT REVISION TOPIC Acoustic neuroma ENT REVISION TOPIC
Acoustic neuroma ENT REVISION TOPIC
 
Cholesteatoma
CholesteatomaCholesteatoma
Cholesteatoma
 
Cholesteatoma CME
Cholesteatoma CMECholesteatoma CME
Cholesteatoma CME
 
Carcinoma of hypopharynx
Carcinoma of hypopharynxCarcinoma of hypopharynx
Carcinoma of hypopharynx
 
Mucosal folds and ventilation of middle ear
Mucosal folds and ventilation of middle ear  Mucosal folds and ventilation of middle ear
Mucosal folds and ventilation of middle ear
 
Petrous apex 360°
Petrous apex 360°Petrous apex 360°
Petrous apex 360°
 
Ossiculoplasty
OssiculoplastyOssiculoplasty
Ossiculoplasty
 
Vestibular schwannoma
Vestibular schwannomaVestibular schwannoma
Vestibular schwannoma
 
Atticotmy
AtticotmyAtticotmy
Atticotmy
 
Endoscopic anatomy of Retrotympanum; Middle ear
Endoscopic anatomy of Retrotympanum; Middle earEndoscopic anatomy of Retrotympanum; Middle ear
Endoscopic anatomy of Retrotympanum; Middle ear
 
Canal wall up Mastoidectomy ( Intact Bridge Mastoidectomy) by Dr.Aditya Tiwari
Canal wall up Mastoidectomy ( Intact Bridge Mastoidectomy) by Dr.Aditya TiwariCanal wall up Mastoidectomy ( Intact Bridge Mastoidectomy) by Dr.Aditya Tiwari
Canal wall up Mastoidectomy ( Intact Bridge Mastoidectomy) by Dr.Aditya Tiwari
 
Middle ear implants
Middle ear implantsMiddle ear implants
Middle ear implants
 
Phonosurgery
PhonosurgeryPhonosurgery
Phonosurgery
 
Stroboscopy
StroboscopyStroboscopy
Stroboscopy
 
Ossiculoplasty
OssiculoplastyOssiculoplasty
Ossiculoplasty
 
Atrophic Rhinitis Slides 050330
Atrophic Rhinitis Slides 050330Atrophic Rhinitis Slides 050330
Atrophic Rhinitis Slides 050330
 
Esthesioneuroblastoma (ENB)
Esthesioneuroblastoma (ENB)Esthesioneuroblastoma (ENB)
Esthesioneuroblastoma (ENB)
 
OTOSCLEROSIS
OTOSCLEROSISOTOSCLEROSIS
OTOSCLEROSIS
 
Glomus Tumour
Glomus TumourGlomus Tumour
Glomus Tumour
 
Phonosurgery
PhonosurgeryPhonosurgery
Phonosurgery
 

Similar to Acoustic neuroma

vestibular schwannoma Dr jyoti singh MS ENT
vestibular schwannoma Dr jyoti singh MS ENTvestibular schwannoma Dr jyoti singh MS ENT
vestibular schwannoma Dr jyoti singh MS ENT
Jyoti Singh
 
Vestibular schwanoma
Vestibular schwanoma Vestibular schwanoma
Vestibular schwanoma
MD Sayad Zaman
 
acousticneuroma-130218031645-phpapp01.pdf
acousticneuroma-130218031645-phpapp01.pdfacousticneuroma-130218031645-phpapp01.pdf
acousticneuroma-130218031645-phpapp01.pdf
Ahmed307578
 
Nasopharyngeal Carcinoma
Nasopharyngeal CarcinomaNasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Balasubramanian Thiagarajan
 
Tumours Of The Cp Afinal Power Pressed
Tumours Of The Cp Afinal Power PressedTumours Of The Cp Afinal Power Pressed
Tumours Of The Cp Afinal Power PressedLiew Boon Seng
 
Acoustic Neuroma
Acoustic NeuromaAcoustic Neuroma
Acoustic Neuroma
Dr Harjitpal Singh
 
Rarecancershn
RarecancershnRarecancershn
Rarecancershn
Navneet Sharma
 
Acoustic schwannoma
Acoustic schwannomaAcoustic schwannoma
Acoustic schwannoma
Drgeeta Choudhary
 
Intracranial Calcification in Cone Beam CT & Medical CT
Intracranial Calcification in Cone Beam CT & Medical CTIntracranial Calcification in Cone Beam CT & Medical CT
Intracranial Calcification in Cone Beam CT & Medical CT
Judy Oh, D.D.S.
 
Acoustic Neuroma causing hearing loss.pptx
Acoustic Neuroma causing hearing loss.pptxAcoustic Neuroma causing hearing loss.pptx
Acoustic Neuroma causing hearing loss.pptx
imranamc1231
 
Thyroid us reggio-emilia 1-tnt
Thyroid us   reggio-emilia 1-tntThyroid us   reggio-emilia 1-tnt
Thyroid us reggio-emilia 1-tnt
Massimiliano Andrioli
 
Presentation2, radiological imaging of neck schwannoma.
Presentation2, radiological imaging of neck schwannoma.Presentation2, radiological imaging of neck schwannoma.
Presentation2, radiological imaging of neck schwannoma.
Abdellah Nazeer
 
CP ANGLE TUMOR.pptx
CP ANGLE TUMOR.pptxCP ANGLE TUMOR.pptx
CP ANGLE TUMOR.pptx
SujanPandey11
 
VESTIBULAR SCHWANNOMA.pptx
VESTIBULAR SCHWANNOMA.pptxVESTIBULAR SCHWANNOMA.pptx
VESTIBULAR SCHWANNOMA.pptx
KarishmaMishra13
 
Tumours of nasopharynx
Tumours of nasopharynxTumours of nasopharynx
Tumours of nasopharynx
aaryaserin
 
Ct & mri of central nervous system
Ct & mri of central nervous systemCt & mri of central nervous system
Ct & mri of central nervous systemghalan
 

Similar to Acoustic neuroma (20)

vestibular schwannoma Dr jyoti singh MS ENT
vestibular schwannoma Dr jyoti singh MS ENTvestibular schwannoma Dr jyoti singh MS ENT
vestibular schwannoma Dr jyoti singh MS ENT
 
Vestibular schwanoma
Vestibular schwanoma Vestibular schwanoma
Vestibular schwanoma
 
acousticneuroma-130218031645-phpapp01.pdf
acousticneuroma-130218031645-phpapp01.pdfacousticneuroma-130218031645-phpapp01.pdf
acousticneuroma-130218031645-phpapp01.pdf
 
Acoustic neuroma
Acoustic neuromaAcoustic neuroma
Acoustic neuroma
 
Nasopharyngeal Carcinoma
Nasopharyngeal CarcinomaNasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
 
Tumours Of The Cp Afinal Power Pressed
Tumours Of The Cp Afinal Power PressedTumours Of The Cp Afinal Power Pressed
Tumours Of The Cp Afinal Power Pressed
 
Acoustic Neuroma
Acoustic NeuromaAcoustic Neuroma
Acoustic Neuroma
 
Rarecancershn
RarecancershnRarecancershn
Rarecancershn
 
Acoustic schwannoma
Acoustic schwannomaAcoustic schwannoma
Acoustic schwannoma
 
Intracranial Calcification in Cone Beam CT & Medical CT
Intracranial Calcification in Cone Beam CT & Medical CTIntracranial Calcification in Cone Beam CT & Medical CT
Intracranial Calcification in Cone Beam CT & Medical CT
 
Acoustic Neuroma causing hearing loss.pptx
Acoustic Neuroma causing hearing loss.pptxAcoustic Neuroma causing hearing loss.pptx
Acoustic Neuroma causing hearing loss.pptx
 
Nasopharyngeal carcinoma
Nasopharyngeal carcinomaNasopharyngeal carcinoma
Nasopharyngeal carcinoma
 
Thyroid us reggio-emilia 1-tnt
Thyroid us   reggio-emilia 1-tntThyroid us   reggio-emilia 1-tnt
Thyroid us reggio-emilia 1-tnt
 
Presentation2, radiological imaging of neck schwannoma.
Presentation2, radiological imaging of neck schwannoma.Presentation2, radiological imaging of neck schwannoma.
Presentation2, radiological imaging of neck schwannoma.
 
CP ANGLE TUMOR.pptx
CP ANGLE TUMOR.pptxCP ANGLE TUMOR.pptx
CP ANGLE TUMOR.pptx
 
VESTIBULAR SCHWANNOMA.pptx
VESTIBULAR SCHWANNOMA.pptxVESTIBULAR SCHWANNOMA.pptx
VESTIBULAR SCHWANNOMA.pptx
 
Tumours of nasopharynx
Tumours of nasopharynxTumours of nasopharynx
Tumours of nasopharynx
 
2010留学生Npc
2010留学生Npc2010留学生Npc
2010留学生Npc
 
8 npc
8 npc8 npc
8 npc
 
Ct & mri of central nervous system
Ct & mri of central nervous systemCt & mri of central nervous system
Ct & mri of central nervous system
 

More from ENTDOST

Anatomy of nose
Anatomy of noseAnatomy of nose
Anatomy of noseENTDOST
 
Anatomy of larynx
Anatomy of larynxAnatomy of larynx
Anatomy of larynxENTDOST
 
Anatomy of inner ear
Anatomy of inner earAnatomy of inner ear
Anatomy of inner earENTDOST
 
Anatomy of ear
Anatomy of earAnatomy of ear
Anatomy of earENTDOST
 
Anatomy n physiology of pharynx 03
Anatomy n physiology of pharynx 03Anatomy n physiology of pharynx 03
Anatomy n physiology of pharynx 03ENTDOST
 
Anatomy and physiology of oral cavity oropharynx waldeyer’s
Anatomy and physiology of oral cavity oropharynx waldeyer’sAnatomy and physiology of oral cavity oropharynx waldeyer’s
Anatomy and physiology of oral cavity oropharynx waldeyer’sENTDOST
 

More from ENTDOST (6)

Anatomy of nose
Anatomy of noseAnatomy of nose
Anatomy of nose
 
Anatomy of larynx
Anatomy of larynxAnatomy of larynx
Anatomy of larynx
 
Anatomy of inner ear
Anatomy of inner earAnatomy of inner ear
Anatomy of inner ear
 
Anatomy of ear
Anatomy of earAnatomy of ear
Anatomy of ear
 
Anatomy n physiology of pharynx 03
Anatomy n physiology of pharynx 03Anatomy n physiology of pharynx 03
Anatomy n physiology of pharynx 03
 
Anatomy and physiology of oral cavity oropharynx waldeyer’s
Anatomy and physiology of oral cavity oropharynx waldeyer’sAnatomy and physiology of oral cavity oropharynx waldeyer’s
Anatomy and physiology of oral cavity oropharynx waldeyer’s
 

Recently uploaded

Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 

Recently uploaded (20)

Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 

Acoustic neuroma

  • 2. INTRODUCTION  An acoustic neuroma (also called vestibular schwannoma) is a benign tumor arising from abnormally proliferative shwann cells , which envelope the lateral portion of the vestibular nerve in
  • 4. CP angle tumors  Represents 10 % of all intracranial tumors.  Fatal without treatment.  VS account for 78 % of CPA tumors - mostly from vestibular branch of VIIIth Nerve.  Variety of other tumors arise from this area like meningioma , CN swannomas , dermoid tumors , arachnoid cysts ,lipomas ,
  • 5. Anatomy of CP angle  CPA – Irregularly shaped potential space in the posterior fossa of the brain .  Anteriorly – posterior surface of temporal bone .  Posteriorly – anterior surface of the cerebellum.  Medially – cisterns of the pons & medulla and olive.  Superiorly – inferior border of pons
  • 6.
  • 7.
  • 8. Anatomy of CP angle  CN s V ( superiorly ) , IX,X,XI (inferiorly ) transverse the cephalic and caudal extent of the CPA.  The central structures crossing the CPA to & from the IAC are CN VII & VIII s carrying with them a fine sheet of arachnoid tissue upto IAC.  Schwann cells sorround these nerves beginning in the IAC , near the porus at the Obersteiner- Redlich zone.
  • 9. Anatomy of CP angle  CN s V ( superiorly ) , IX,X,XI (inferiorly ) transverse the cephalic and caudal extent of the CPA.  The central structures crossing the CPA to & from the IAC are CN VII & VIII s carrying with them a fine sheet of arachnoid tissue upto IAC.  Schwann cells sorround these nerves beginning in the IAC , near the porus at the Obersteiner- Redlich zone.
  • 10. Anatomy of CP angle AICA is the main artery in the CPA and is the source of the labrynthine artery . The labrynthine artery courses via the IAC & is an end artery for the hearing and balance organs.
  • 11. Vestibular schwannoma Nerve sheath tumors of the superior and inferior vestibular nerves. They arise in the medial part of the IAC or the lateral part of the CPA and cause clinical symptoms by displacing , distorting or compressing
  • 12. Vestibular schwannoma  Mean incidence range – 9.1 tmr/yr to 13 tmr/yr( as per SB)  0.7 to 1.2 VS per lakh population/yr ( ballenger )  Types - Sporadic ( 95%) and non sporadic ( 5%)  Age of presentation – 40 to 60 yrs.  Age of presentation is less in non sporadic ( 20-30 yrs )
  • 13. Tumor biology  Equal frequency in sup and inf vestibular ( but recent japanese studies suggested 85 % from inf vestibular )  Arise from schwann cells within the IAC – lateral to O-R zone in the area of scarpa ganglion.  Schwannomas rarely arise from the cochlear nerve & are rarely
  • 14. Tumor pathogenesis  Owing to mutations in the gene for the tumor suppresor protein MERLIN located on chr 22q12.  Formation of VS requires mutation of both copies of the merlin gene.  Somatic mutations in both copies of merlin gene results in sporadic VSs .  Familial VS occuring in NF 2 requires only one somatic mutation event .( inherit one )
  • 15. Tumor pathogenesis  NF2 is autosomal recessive at gene level but inheritance is autosomal dominant ( pseudodominant )  A mutation in the normal allele leads to bilateral VS by the age of 20.  Genetic screens for the NF2 mutation have been developed and are the basis for genetic counselling for family members of NF2 patients
  • 16. Tumor pathogenesis  Biochemical factors- VS express neuregulin ,which controls survival and proliferation of schwann cells and its receptors erbB2 & erbB3.  FGF ,TGF B1 , PDGF & VEGF all these contribute to VS proliferation.  VS may accelerate during pregnancy.
  • 17. pathology  GROSS : ◦ VS have a smooth surface with a yellow to gray color. ◦ Tumor is usually solid ,with occasional cystic components and therefore has a firm to soft texture depending on solid to cystic components.  MICROSCOPIC : ◦ Capsule – 3 to 5 micrometer in thickness. ◦ Two morphological tissue types – Antony A & Antony B areas
  • 18. T UMOR DEVELOPMENT Develops in nerve sheath Compresses rather than invading the nerve Gradually fills all the IAC Protrudes out of the porus
  • 19. T UMOR DEVELOPMENT- extrameatally Extrameatal expansion into the large & empty pontine cistern Displacement and stretching of the VII & VIII th CN on the anterior Compress cerebellum and trigeminal N aspect of the tumor & of the AICA on the inferior aspect (During this time IAM continues to become more & more widened ) which leads gradually to hydrocephalus
  • 20. T UMOR DEVELOPMENT- extrameatally Tumor may extent to the tentorium & can obstruct the cochlear aqueduct The AICA & lower cranial nerves are also displaced & become closely Overtime , the trigeminal & abducens Adherent to the inf surface of tumor. over the surface of the tumor and get thinned.
  • 22. Tumor development…..  Periods of growth are intermixed b/w slow growth & peroid of quescence.  Occasionally tumor may undergo rapid expansion owing to cystic degeneration or hemmorhage into the tumor.  The initial intracanalicular growth effects the vestibulocochlear nerve
  • 23.
  • 25.
  • 27. Large Acoustic Neuroma: Tumors over 2.5 centimeters (this one is 2.6 cm) become impacted into the brainstem and cerebellum. Complications associated with surgery and radiation are higher. It is difficult to deliver an adequate dose of radiation to control tumor growth without excessive dosing to the brainstem in tumors larger than this.
  • 28.
  • 29. Symptoms & signs  Intracanalicular: ◦ Hearing loss (UL progressive ), tinnitus, vertigo ◦ Loss of speech discrimination out of propotion to HL  Cisternal: ◦ Worsened hearing and dysequilibrium  Compressive: ◦ Occasional occipital headache ◦ CN V: Midface, corneal hypesthesia ◦ CN VII : Hitzelberger’s sign, loss of taste and reduced lacrimation on Schirmer’s test ,facial weakness ( late) ◦ CN II , IV , VI : visual acquity and diplopia
  • 30. Symptoms & signs  Hydrocephalic: ◦ Fourth ventricle compressed and obstructed ◦ Headache, visual changes, altered mental status ◦ Nausea and vomiting ◦ On examination : ICP and pappiledema.  Compression of CN IX & X ◦ Dysphagia , aspiration and hoarseness ◦ Poor gag reflex and VC paralysis.  Cerebellar involvement( late ) ◦ Incoordination , widely based gate , tendency to fall owards affected side
  • 31. Symptoms & signs  Brainstem involvement: • There is ataxia, weakness and numbness of arms and legs with exaggerated tendon reflexes.
  • 32. Jackler Staging System STAGE TUMOUR SIZE Intra canalicular Tumour confined to IAC I (Small) <10mm II(Medium) 11-25mm III(Large) 25-40mm IV(Giant) >40mm
  • 34. Duration of Symptoms Prior to Diagnosis SYMPTOMS YEARS Hearing loss 3.9 Vertigo 3.6 Tinnitus 3.4 Headache 2.2 Dysequilibrium 1.7 Trigeminal 0.9 Facial 0.6
  • 35. Diagnostic evaluation  Average patient will require 4 years from the onset of symptoms to diagnosis.  Majority will present with complaints of UHL, UT, Vertigo , dysequilibrium, facial numbness , weakness or spasm.  Initial step in evaluation includes an audiologic assessment .if it suggests a retrocochlear lesion , then imaging of the CPA is performed .  Vestibular testing lacks specificity in diagnosis of VS
  • 36. AUDIOLOGICAL EVALUATION  Includes PTA , Speech discrimination score (SDS) , Acoustic reflex threshold & acoustic reflex decay  PTA of patients with VS shows assymetric , down sloping , high frequency SNHL in almost 70% of patients
  • 37. AUDIOLOGICAL EVALUATION  Retrocochlear HL causes SDS to be lower than predicted by the pure tone thresholds.  This out of propotion is furthur accenuated when retested at a higher speech intensity ( roll over phenomenon )  Loss of acoustic reflex or acoustic reflex decay is noted in most patients with VS
  • 38. audiological tests Cochlear Retrocochlear a) Pure tone audiometry Sensorineural hearing loss Sensorineural hearing loss b) Speech discrimination score <90% Very poor c) Roll over phenomenon Absent Present d) Recruitment Present Absent e) SISI Over 70% 0-20% f) Threshold tone decay test <25db >25db g) Stapedial reflex Present Absent i) Stapedial reflex decay test Normal Absent
  • 39. VESTIBULAR TESTING  Not sensitive nor specific for diagnosing VS  The MC test used is ENG with caloric testing.  Shows reduced caloric response in the affected ear.  The extent of vestibular function present predicts the amount of post op vertigo.  The location of VS on the inf or sup Vestibular N may also be predicted.
  • 40. AUDITORY BRAINSTEM RESPONSE  In patients with VS , the ABR is partially or completely absent , or there is a delay in latency of wave V on the affected side.  An interaural delay of wave V greater than 0.2 ms is considered abnormal. ( 40-60 % )  Overall ABR has a sensitivity of > 90% & specificity of > 90 % in detecting VS.
  • 41. AUDITORY BRAINSTEM RESPONSE  In 20-30 % there are no identifiable waveforms even with insignificant HL in higher frequencies.  In 10-20 % only wave I is present.
  • 43. Imaging studies  VS is definitely identified MC via an imaging study.  Earlier plain film radiograghs and polytomographs  Introduction of CT in 1970 allowed axial imaging with improved bone & soft tissue evaluation.  With the addition of iv iodinated contrast agent ,90 % of VS are enhanced furthur improving diagnostic accuracy.
  • 44. Imaging studies  Intracanalicular tumors & tumors extending less than 5 mm into the CPA frequently are missed with contrast enhanced CT.  Accuracy improved by air-contrast cisternography.  MRI was introduced in 1980 & has become the GOLD standard for VS
  • 45. Imaging studies  MRI :  VII & VIII nerves as well as cerebellum ,brainstem , vasculature & other structures are well visualized on MRI  The addition of gadolinium furthur enhanced the diagnostic accuracy  Typically a series of T1 weighed images in which CSF is dark and fat is bright, T1 with gadolinium contrast , T2 In which CSF is bright is used.  A hypointense globular mass centered over the IAC on T1 With enhancement on gadolinium.  VS are iso-to hypointense on T2.  T2 fast spin echo MRI without contrast as screening.
  • 46. MRI Brain Isointense to brain, hyperintense to CSF Hyperintense to brain, hypointense to CSF
  • 47. management options  The primary management of VSs is surgical removal.  Roles of observation and radiotherapy are currently for the pts,who cannot tolerate a surgical procedure or have a life span of < 5 yrs.  Surgical approaches to the CPA include: ◦ Translabrynthine ◦ Retrosigmoid ◦ Middle fossa craniotomies.
  • 48. management options  The appropriate approach for a particular pt. is based on the hearing status , size of the tumor , extent of IAC involvement and experience of the surgeon  The approaches are either hearing preservative or ablating.  The retrosigmoid & middle fossa approaches are hearing preserving, while translabrynthine approach is otherwise.
  • 49. management options  The middle fossa approach is well suited for the pts with good hearing and tumor<2cm.  The retrosigmoid approach is well suited for those with good hearing and tumor<4cm and not involving the lateral part of IAC.  The translabrynthine approach causes total hearing loss and so is appropriate for the pts with poor hearing(PTA>30dB) or pts with good hearing and tumors not accessible by the hearing preserving approach.
  • 50. management options  Three critical issues inherent to all the three techniques are: ◦ Extent of exposure of IAC and CPA ◦ Identification and preservation of the facial nerve ◦ extent of brain retraction  These operations use electro physiologic monitoring of CN VII and ABR in hearing preserving approach.
  • 51. Middle Fossa Approach. Translabyrinthine Approach Suboccipital Approach Surgical Approaches Factors that influence surgical approach selection •Age •Hearing status •Tumour size •Surgeon’s preference.
  • 52. Translabrynthine approach  The primary approach for removal of VS.  Most direct route to the CPA & requires minimal cerebellar retraction.  Identification of facial n is possible.  Surgeons can ensure complete removal bcz fundus of IAC is widely exposed.  Immediate repair of facial n possible.  Recovery is quite rapid with minimal pain and excellent facial n results
  • 53. Translabrynthine approach  Obvious disadvantage is sacrifice of any residual hearing.  Technique : ◦ A postauricular incision is made 2 cm behind sulcus ◦ Complete mastoidectomy is done,with identification of the middle fossa dura, sigmoid sinis , LSSC , fossa incudis & facial n ◦ The sigmoid sinus is decompressed with a diamond burr
  • 54. Translabrynthine approach ◦ A labrynthectomy is begun by removal of bone in the sinodural angle along the horizontal scc ◦ Each SCC is then opened and followed into the vestibule, with care taken to identify the ampulla of each SCC and the subarcuate artery ◦ A bone is removed along the posterior fossa dura medial to sigmoid sinus , the endolymphatic duct and sac are encountered.
  • 55. Translabrynthine approach ◦ Jugular bulb location is defined by locating ampulla of posterior canal. ( inferior extent of dissection ) ◦ Bone is removed around the inferior aspect of IAC until the cochlear aqueduct is identified ◦ Posterior aspect of the canal is skeletonized until the superior edge of the internal canal is identified ◦ Bone is then carefully removed between th e middle fossa dura & the IAC
  • 56. Translabrynthine approach ◦ Once the medial portion of the IAC is exposed for 270 the remaining piece of porus may be carefully removed ◦ Laterally the transverse crest should be identified at the fundus of the IAC. ◦ Superiorly , the Bills Bar is identified together with the labrynthine portion of the facial n ◦ The posteroir fossa dura is opened inferior to and parallel to the superior petrosal sinus over the midportion of the IAC 0
  • 57. Translabrynthine approach ◦ Using the bills bar as guide , and with a fine hook , the surgeon seperates the superior vest n from facial nerve. ◦ The capsule of the tumor is incised , & the tumor is gutted with house urban dissector 0
  • 58.
  • 59.  Radiotherapy :- 1. Conventional radiotherapy by external beam has no role in the treatment of Acoustic Neuromas due to low tolerance of CNS to radiation. 2. X – or Gamma knife surgery.